Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
about
Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 DiabetesThe pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over timeSkeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exerciseSerum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controlsα1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetesInhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes.Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetesLutein dietary supplementation attenuates streptozotocin-induced testicular damage and oxidative stress in diabetic ratsNon-cell autonomous influence of the astrocyte system xc- on hypoglycaemic neuronal cell death.Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat.Th17 cells in human disease.Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.Innate inflammation in type 1 diabetesDysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetesIncreased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients.Blood-based signatures in type 1 diabetes.The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2.Interleukin-1 stimulates catabolism in C2C12 myotubes.Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells.The role of MIF in type 1 and type 2 diabetes mellitus.Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes.Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.Pancreatic islet inflammation: an emerging role for chemokines.Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus.Association between IgE-mediated allergies and diabetes mellitus type 1 in children and adolescents.Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1β-mediated inhibition of glucose-stimulated insulin secretion by mouse insulinoma β cells.
P2860
Q27349718-D717A3E7-FB2A-46A3-A848-1F208FE070E6Q28285897-B55B19C7-936D-4DD9-8D3D-F5EF98F205D0Q28566793-775B98FF-E70D-4686-BDCE-E5BF1F6E8354Q33786938-87D70E38-17E6-4102-9574-716A15A22C0BQ33999020-81409E19-44C3-4F8C-A8AF-D6EC0C18B082Q34072307-D95FE293-B183-4639-BF9B-483AD94EA2B1Q34666831-418D21A0-792D-40BD-B8C7-1B9088A6961AQ34693197-0E4D5B04-A313-4FDC-8159-9608CAD1F631Q35053311-7A762786-DCA2-4E27-810E-61FFD0A9DBE1Q35062538-9F21ED5D-73C6-4062-BC99-15F4D50F4589Q35677591-DF4535FA-7777-48B2-8C6E-5E853586F2D4Q35744426-7D715200-6F10-4636-91F2-BD0D7DF31CD1Q35757080-85A2E176-C01A-465A-BAC4-66D62FB05955Q35820734-AFB02816-FF3E-462D-A999-D148524E8907Q35860851-1634C2C3-47C9-415A-9E8A-F16667A6D06FQ36225939-566E5128-9DA3-423C-A742-8CB75A20D7CDQ36249702-CED63EAD-8EB3-4DA8-B773-1B4529FE2960Q36335960-701140E9-FF9A-41A1-A722-8DCFCF278BD4Q36364298-23C81C98-5113-4B10-89B6-0640764EF072Q36552481-B480E25F-C68B-4549-96AA-0E2588871253Q36679011-2A957BF5-06B4-4266-9CEE-3C3EDD6439FBQ36680316-6A053EF6-5700-412B-A080-65422F77D0BAQ36711831-B7C18BE3-459D-430A-9B16-8BDDA5FDF67DQ36788764-83E29601-3AD8-40AF-A811-D0E36A00CA0EQ37330708-E1AD0EB5-2BE3-4563-A449-EE702D9E9539Q37338915-362FDEE2-8051-4ECD-8616-ECF4EA29F511Q37399738-05BE5600-58F2-42D4-BEF7-89A9CBFD6290Q37405753-5A271228-F6E9-4185-A156-B649540DCFE9Q37542812-DCB5C9FB-C1F2-4F2E-A78C-EE236CB78CBBQ37598215-13B23337-4C89-4BE2-88F8-C6FB30675FE6Q37984231-D3CBA495-4EBA-48DD-892E-8CD35900A642Q38235580-5E8BC197-8604-4755-A93B-18D26A8AC938Q38390695-381E6943-1E3F-4D6F-8243-80CADF3AC72FQ38706264-CCB5CA12-6ACE-433E-8B4C-A3EEDFAE9467Q38797855-38505236-3101-41A0-BB9D-97FF5A9C6BD1Q39249398-3BA882AB-CF18-4E4B-94F7-E18734485C81Q40162151-9F8F3CEB-619F-4661-BF03-745FA2EFA55BQ40703127-9C821539-0D00-44E7-A9D2-ADE6D2041825Q41572131-35FD0219-CC55-4EDA-B4A7-B3ACFBE82A80Q41692104-10917EB9-764C-4CFA-86E1-813EB11EF9A4
P2860
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@ast
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@en
type
label
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@ast
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@en
prefLabel
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@ast
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@en
P2093
P2860
P356
P1476
Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children
@en
P2093
Bilal Ustundag
Erdal Yilmaz
Metin Kaya Gurgoze
Saadet Akarsu
Yasar Dogan
P2860
P356
10.1155/MI/2006/59206
P577
2006-01-01T00:00:00Z